Rocket Lab Stock Could Be Headed for a Breakout. Here’s My 2027 Price Prediction
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Rocket Lab (NASDAQ:RKLB | RKLB Price Prediction) has grown well beyond its small-rocket roots. It now builds full spacecraft, laser communications terminals and robotics, then launches many of them on its own Electron and HASTE rockets.
After the third quarter, CEO Peter Beck said “the world’s most critical and ambitious missions increasingly rely on Rocket Lab for launch, spacecraft, and components, sometimes all on a single mission.”
The stock has lagged that progress. Shares fell 8.16% year-to-date through Thursday’s close and traded at $60.10 Friday morning. That’s far below the 52-week high of $151. Over five years, though, shares are still up 345.86%. Several things would need to fall into place for Rocket Lab to hit $100 in 2027.
Wall Street Sees More Than 60% Upside From Here
The average analyst price target is $96.50, which implies about 61% upside. Coverage is weighted toward the bulls, with 5 strong buy and 13 buy ratings against 4 holds and zero sells.
Analysts expect revenue to climb from $959.2 million in 2026 to $1.33 billion in 2027, growth of roughly 39%. They also see the loss per share narrowing from -$0.2748 to -$0.0912.
Rocket Lab has beaten revenue estimates in each of its last seven reported quarters, so the top line could come in ahead of forecasts. Its third-quarter GAAP EPS of -$0.12 missed expectations, mostly because of a $27.26 million debt repayment loss and $21.34 million in Iridium Communications (NASDAQ:IRDM) deal costs.
Here’s What It Takes for Rocket Lab to Reach $100
Rocket Lab still loses money, so price-to-sales is the better metric. Shares currently trade at about 29x estimated 2027 revenue. At $100, that multiple would rise to roughly 47x. That’s a steep premium, and it would need near-39% growth plus visible progress on Neutron to hold up. Reaching $100 means a 66% gain.
What Could Push Rocket Lab to $100?
- Neutron’s debut: The first launch is targeted for 2027. 16 launches are already booked, at a base price of $70 million. The CFO expects adjusted EBITDA to turn positive within six months of the first successful test flight.
- Record backlog: Backlog reached $3.57 billion, up 52% since Q2. About 32.9% of it should convert to revenue within 12 months.
- Defense spending: The FY 2027 budget request includes $17.9 billion for Golden Dome. Rocket Lab was selected alongside RTX (NYSE:RTX) unit Raytheon for its Space Based Interceptor work, and it also holds an $816 million SDA contract.
- Electron momentum: CFO Adam Spice expects launch growth “should be better in many ways next year than we even saw from ’25 to ’26.”
- Iridium: Closing the fully funded deal would add recurring communications revenue.
Rocket Lab’s History Says a 66% Gain Is Within Reach
Gains this size are routine for Rocket Lab. Shares rose 361% in 2024 and 174% in 2025. This year, the stock more than doubled from its 2025 close to a May month-end of $143.48.
That volatility runs both ways: shares fell from $12.28 to $3.77 in 2022, and the beta of 3.176 points to big moves in either direction.
$100 Is a Stretch, but Here’s Why It’s Possible
Hitting $100 requires a 66% gain, only slightly above the Street’s $96.50 target. Revenue growth near 39%, a record backlog and a Neutron launch could all drive the stock higher.
Hurdles remain: Neutron has been delayed before, and the ATM program issued 36.8 million shares. Non-GAAP gross margin also dropped to 38.4% from 41.9%.
Gains of this magnitude are rare in any single year, but Neutron, the backlog and defense spending form the plan for how Rocket Lab could deliver outsized returns in 2027. The kind of early-stage tech setup Rocket Lab represents is exactly the pattern we reverse-engineered from past 100x winners in a free playbook you can grab here.
Contact [email protected] for any questions or corrections.






